Yun Bi

Shiyan, 442000, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Pan-cancer 8q24 amplification predicts primary immunotherapy resistance and therapeutic vulnerabilities.

Pan-cancer 8q24 amplification predicts primary immunotherapy resistance and therapeutic vulnerabilities.

Journal: iScience
Published: December 20, 2025

CD266+ myofibroblasts mediate resistance to immunochemotherapy through ECM stiffness in head and neck squamous cell carcinoma.

CD266+ myofibroblasts mediate resistance to immunochemotherapy through ECM stiffness in head and neck squamous cell carcinoma.

Journal: Cancer immunology research
Published: November 04, 2025

Pembrolizumab With Anlotinib in Advanced Oral Mucosal Melanoma: A Retrospective Trial.

Pembrolizumab With Anlotinib in Advanced Oral Mucosal Melanoma: A Retrospective Trial.

Journal: Oral diseases
Published: August 06, 2025

Pristimerin induces apoptosis and tumor inhibition of oral squamous cell carcinoma through activating ROS-dependent ER stress/Noxa pathway.

Pristimerin induces apoptosis and tumor inhibition of oral squamous cell carcinoma through activating ROS-dependent ER stress/Noxa pathway.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: March 05, 2021

CXCL13 promotes intestinal tumorigenesis through the activation of epithelial AKT signaling.

CXCL13 promotes intestinal tumorigenesis through the activation of epithelial AKT signaling.

Journal: Cancer letters
Published: February 07, 2021

RIPK3 Suppresses the Progression of Spontaneous Intestinal Tumorigenesis.

RIPK3 Suppresses the Progression of Spontaneous Intestinal Tumorigenesis.

Journal: Frontiers in oncology
Published: February 06, 2021

MLKL inhibits intestinal tumorigenesis by suppressing STAT3 signaling pathway.

MLKL inhibits intestinal tumorigenesis by suppressing STAT3 signaling pathway.

Journal: International journal of biological sciences
Published: November 19, 2020

Effect of pristimerin on apoptosis through activation of ROS/ endoplasmic reticulum (ER) stress-mediated noxa in colorectal cancer.

Effect of pristimerin on apoptosis through activation of ROS/ endoplasmic reticulum (ER) stress-mediated noxa in colorectal cancer.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: June 04, 2020

Pristimerin protects against inflammation and metabolic disorder in mice through inhibition of NLRP3 inflammasome activation.

Pristimerin protects against inflammation and metabolic disorder in mice through inhibition of NLRP3 inflammasome activation.

Journal: Acta pharmacologica Sinica
Published: April 28, 2020

Gambogenic acid induces Noxa-mediated apoptosis in colorectal cancer through ROS-dependent activation of IRE1α/JNK.

Gambogenic acid induces Noxa-mediated apoptosis in colorectal cancer through ROS-dependent activation of IRE1α/JNK.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: March 13, 2020

10,11-dehydrocurvularin exerts antitumor effect against human breast cancer by suppressing STAT3 activation.

10,11-dehydrocurvularin exerts antitumor effect against human breast cancer by suppressing STAT3 activation.

Journal: Acta pharmacologica Sinica
Published: March 08, 2020

Pristimerin Induces Autophagy-Mediated Cell Death in K562 Cells through the ROS/JNK Signaling Pathway.

Pristimerin Induces Autophagy-Mediated Cell Death in K562 Cells through the ROS/JNK Signaling Pathway.

Journal: Chemistry & biodiversity
Published: June 10, 2019
Showing 1-12 of 14

Last Updated: 09/26/2026